Table 3.
Baseline characteristics of study participants, stratified by treatment era of diagnosis
| Total (n = 420) | Pre-UTT (n = 154) | UTT (n = 266) | |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Sex | |||
| Female | 389 (92.6) | 146 (94.8) | 243 (91.4) |
| Male | 31 (7.4) | 8 (5.2) | 23 (8.6) |
| Age at diagnosis (median/IQR) | 22.2 (20.4–23.7) | 22.3 (20.7–23.6) | 22.2 (20.3–23.6) |
| CD4 cell count at diagnosis/entry into care (median/IQR)† | 333 (217–458) | 329 (200–438) | 334 (221–483) |
| <200 cells/mm3 | 74 (22.5) | 32 (24.8) | 42 (21.0) |
| ≥200 cells/mm3 | 255 (77.5) | 97 (75.2) | 158 (79.0) |
Abbreviations: IQR- interquartile range; UTT- Universal Test and Treat
†missing baseline CD4 n = 91